Spontaneous bilateral chylothorax development during alectinib therapy for ALK-rearranged NSCLC—A case report Journal Article
| Authors: | Bajaj, S.; Chow, A.; Drilon, A.; Kalchiem-Dekel, O. |
| Article Title: | Spontaneous bilateral chylothorax development during alectinib therapy for ALK-rearranged NSCLC—A case report |
| Abstract: | The emergence of spontaneous nonmalignant chylous effusions during treatment with various tyrosine kinase inhibitors (TKIs) has been previously described; however, there have been no prior reports for alectinib. Herein, we report a case of symptomatic bilateral chylothorax during alectinib therapy in a patient with ALK-rearranged lung adenocarcinoma. Although immediate control of symptoms was achieved by placement of bilateral tunneled pleural catheters, the chylothorax ultimately resolved only after alectinib discontinuation and transition to an alternative TKI. This case adds alectinib to the growing list of TKIs that may be associated with the rare emergence of spontaneous, nonmalignant chylous effusions. © 2023 The Authors |
| Keywords: | case report; lung adenocarcinoma; chylothorax; alectinib |
| Journal Title: | JTO Clinical and Research Reports |
| Volume: | 4 |
| Issue: | 12 |
| ISSN: | 2666-3643 |
| Publisher: | Elsevier BV |
| Date Published: | 2023-12-01 |
| Start Page: | 100606 |
| Language: | English |
| DOI: | 10.1016/j.jtocrr.2023.100606 |
| PROVIDER: | scopus |
| PMCID: | PMC10755351 |
| PUBMED: | 38162174 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF. Corresponding MSK author is Alexander Drilon -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work